1Minerva Center for Calcium and Bone Metabolism, Nephrology and Hypertension Services, Hadassah Hebrew University Medical Center, Jerusalem, Israel. silver@huji.ac.il
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New oral phosphorus binders like sevelamer hydrochloride offer promise for chronic kidney disease patients. However, the DCOR study found no clear superiority over calcium-based binders for dialysis patients.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: